Lansoprazol Pensa

Lansoprazole, the active ingredient in Lansoprazol Pensa, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease, Helicobacter pylori infection and erosive oesophagitis in adults. GNH USA supplies Lansoprazol Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid‑secretion pathway to manage several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn, regurgitation and mucosal damage. - Peptic ulcer disease: promotes ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication: enhances antibiotic efficacy as part of combination therapy. - Erosive oesophagitis: heals erosive lesions and prevents recurrence.

Adverse reactions may occur with lansoprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhoea and colitis. - Hepatic enzyme elevation: signs of liver injury. - Hypomagnesemia: low magnesium levels with long‑term use. - Interstitial nephritis: kidney inflammation. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Monitor magnesium levels: long‑term therapy may cause hypomagnesemia. - Review concomitant medications: avoid use with drugs that require acidic pH for absorption. - Use in pregnancy only if benefit outweighs risk: limited data available. - Store at room temperature: keep in the original pack, protect from moisture and light.

Lansoprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and antiviral activity. - Methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Digoxin: potential increase in serum concentrations. - Phenytoin: possible reduction in phenytoin levels.